Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR Diabetes (no longer under consideration since Nov 03, 2023)

Date Submitted: Sep 28, 2023
Open Peer Review Period: Sep 28, 2023 - Oct 24, 2023
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Comparison of reliability of Bluetooth connectivity between two interoperable continuous glucose monitoring systems: Comparison study

  • Greg Scott; 
  • Jean-Pierre Cole; 
  • Kendall Covington

ABSTRACT

This study evaluates Bluetooth Low Energy (BLE) connectivity in modern continuous glucose monitoring systems (CGMs) for diabetes management. With a focus on FreeStyle Libre 3 and Dexcom G7, the research examines reliability during daytime and nighttime wear by analyzing data gaps in BLE transmission between the sensor and receiver. A sample of 12 participants provides insights into prevalence, duration, and potential implications of these gaps. Results show that L3 achieved an average BLE transmission rate of 93.5% compared to G7's 69.3%, with G7 exhibiting greater variation. Furthermore, G7 experienced significantly more frequent and longer data gaps, highlighting potential limitations in signal reliability. These findings suggest the importance of consistent and reliable data transmission for informed medical decisions and alarm systems. The study underscores the need for patient awareness and future studies to assess the impact of BLE connectivity on patient safety, particularly in the context of integrating CGMs with insulin pumps.


 Citation

Please cite as:

Scott G, Cole JP, Covington K

Comparison of reliability of Bluetooth connectivity between two interoperable continuous glucose monitoring systems: Comparison study

JMIR Preprints. 28/09/2023:53190

DOI: 10.2196/preprints.53190

URL: https://preprints.jmir.org/preprint/53190

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.